12:00 AM
Mar 19, 2012
 |  BC Week In Review  |  Company News  |  Deals

Horizon Discovery Ltd., Rosalind Franklin University of Medicine and Science, North deal

The biotech and university partnered to develop a human cellular disease model of cystic fibrosis. The university will receive a perpetual academic research license to Horizon's GENESIS recombinant adeno-associated virus (rAAV) gene editing technology,...

Read the full 146 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >